The global Ureteral Stents Market is witnessing steady growth as the prevalence of kidney stones, urinary tract infections (UTIs), ureteral obstructions, and other urological disorders continues to increase worldwide. The demand for minimally invasive urological procedures, coupled with technological advancements in stent materials and designs, is significantly contributing to market expansion.
According to the latest market analysis, the global Ureteral Stents Market was valued at US$ 488.2 Mn in 2022 and is projected to surpass US$ 823.7 Mn by 2031, expanding at a CAGR of 5.9% from 2023 to 2031.
Growing awareness regarding early diagnosis of urinary tract disorders, increasing healthcare expenditure, and improved access to specialized urological care are further supporting market growth. Continuous innovation in biodegradable stents, drug-eluting stents, antimicrobial coatings, and patient-friendly designs is expected to enhance treatment outcomes while reducing complications associated with long-term stent placement.
→Discover Market Opportunities – Request Your Sample Copy Now: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=25988
Rising Burden of Urological Disorders Drives Market Growth
One of the primary drivers of the ureteral stents market is the growing prevalence of urological disorders globally.
Kidney stones remain one of the most common urinary tract disorders affecting millions of individuals each year. Rising incidences of urinary tract infections, ureteral strictures, tumors, urinary obstruction, kidney injuries, and post-surgical complications are also contributing to increasing demand for ureteral stents.
Lifestyle-related factors including inadequate hydration, obesity, unhealthy dietary habits, diabetes, sedentary lifestyles, and increasing aging populations have significantly increased the occurrence of urinary disorders.
Older adults are particularly vulnerable to kidney stones, urinary obstruction, and chronic kidney diseases, making them major users of ureteral stents during diagnostic and therapeutic procedures.
Furthermore, increasing cases of prostate cancer, bladder cancer, and other urological malignancies frequently require temporary ureteral stenting to maintain urine drainage before, during, or after surgical interventions.
As the global burden of urological diseases continues to rise, healthcare providers increasingly rely on ureteral stents to restore urinary flow, preserve kidney function, and prevent long-term complications.
Growing Awareness and Early Diagnosis Support Market Expansion
Improved awareness regarding urinary health has significantly increased early diagnosis and treatment of urological disorders.
Healthcare organizations, urological associations, hospitals, and physicians continue emphasizing regular health screenings and prompt diagnosis of urinary tract abnormalities before complications develop.
Early identification of ureteral obstruction, kidney stones, infections, and urinary tract abnormalities enables timely intervention using minimally invasive techniques involving ureteral stent placement.
Timely diagnosis reduces the risk of kidney damage, urinary infections, renal failure, and permanent loss of kidney function.
Advances in imaging technologies including CT scans, ultrasound, MRI, and endoscopic procedures have also improved diagnostic accuracy, allowing physicians to identify urinary tract disorders more efficiently.
The increasing focus on preventive healthcare, patient education, and regular urological examinations is expected to strengthen demand for ureteral stents throughout the forecast period.
Technological Advancements Transform Ureteral Stent Design
Continuous innovation remains one of the defining characteristics of the global ureteral stents market.
Manufacturers are developing next-generation stents that offer improved patient comfort, longer durability, reduced complications, and easier insertion and removal procedures.
Traditional silicone and polyurethane stents are now being complemented by advanced biodegradable hydrogel stents, metallic stents, hybrid materials, and drug-eluting technologies.
Drug-eluting ureteral stents gradually release therapeutic agents that reduce inflammation, bacterial colonization, and tissue irritation, thereby improving patient outcomes.
Biodegradable ureteral stents represent another significant technological advancement. These stents gradually dissolve after completing their intended function, eliminating the need for secondary removal procedures and reducing patient discomfort.
Manufacturers are also investing in antimicrobial surface coatings designed to minimize bacterial biofilm formation and lower the incidence of urinary tract infections associated with prolonged stent placement.
Improved flexibility, enhanced biocompatibility, optimized drainage efficiency, and anti-encrustation technologies continue transforming the clinical performance of modern ureteral stents.
Increasing Preference for Minimally Invasive Urological Procedures
The widespread adoption of minimally invasive urological procedures is significantly contributing to market growth.
Procedures such as ureteroscopy, laser lithotripsy, endoscopic stone removal, and cystoscopic interventions routinely utilize ureteral stents to ensure proper urinary drainage during postoperative recovery.
Compared with traditional open surgeries, minimally invasive procedures offer shorter hospital stays, reduced surgical trauma, lower complication rates, faster patient recovery, and improved clinical outcomes.
As healthcare providers increasingly adopt minimally invasive treatment protocols, the utilization of ureteral stents continues expanding across hospitals, ambulatory surgical centers, and specialty urology clinics.
Growing patient preference for faster recovery and less invasive treatment options further supports widespread adoption of advanced ureteral stenting procedures.
Government Healthcare Investments Create Growth Opportunities
Government investments aimed at strengthening healthcare infrastructure are creating favorable opportunities for the ureteral stents market.
Several countries continue expanding access to specialized urological care through improved hospital infrastructure, increased healthcare funding, expanded insurance coverage, and national screening programs.
Developing economies are witnessing rapid modernization of healthcare systems, enabling broader access to advanced diagnostic technologies and minimally invasive surgical procedures.
Improved reimbursement policies in many regions are encouraging healthcare providers to adopt advanced medical devices, including innovative ureteral stents offering superior clinical performance.
Growing public healthcare expenditure and private investment in urology services are expected to generate sustained demand for ureteral stents over the coming years.
Challenges Limiting Market Growth
Despite positive growth prospects, the ureteral stents market continues facing several challenges.
Advanced ureteral stents incorporating drug-eluting technologies, antimicrobial coatings, or biodegradable materials often involve higher manufacturing costs, limiting widespread adoption in price-sensitive healthcare markets.
Inconsistent reimbursement policies across certain countries further restrict patient access to premium stent technologies.
Clinical complications remain another important concern. Stent migration, encrustation, urinary tract infections, patient discomfort, urinary urgency, hematuria, and tissue irritation continue affecting clinical outcomes in some patients.
Long-term indwelling stents require careful monitoring to prevent infection, mineral deposition, and blockage.
Manufacturers continue focusing research efforts on developing improved stent materials capable of reducing these complications while maximizing patient comfort and long-term safety.
→Explore Strategies & Trends – Request Full Report Access – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=25988
Double Pigtail Stents Dominate the Product Segment
Based on product type, Double Pigtail Stents accounted for the largest share of the global ureteral stents market.
These stents remain the preferred choice among urologists due to their superior anchoring capability, which significantly reduces the likelihood of stent migration or accidental displacement.
Their characteristic curled ends securely position the stent within both the kidney and bladder, ensuring consistent urinary drainage throughout treatment.
Double pigtail stents also offer excellent patient comfort, improved drainage efficiency, reduced irritation, and lower rates of repositioning compared with several alternative designs.
Advances in material flexibility and surface engineering have further strengthened their clinical performance across multiple urological applications, including kidney stones, ureteral obstruction, postoperative drainage, and urinary tract reconstruction.
Their widespread clinical acceptance is expected to maintain segment leadership throughout the forecast period.
North America Leads the Global Ureteral Stents Market
North America continues holding the largest share of the global ureteral stents market.
The region benefits from highly developed healthcare infrastructure, widespread adoption of advanced medical technologies, strong reimbursement systems, and high awareness regarding urological health.
The United States experiences a significant burden of kidney stones, urinary tract infections, bladder disorders, prostate diseases, and other urological conditions requiring ureteral stenting.
An aging population, increasing obesity rates, diabetes prevalence, and sedentary lifestyles continue contributing to rising demand for urological interventions throughout the region.
Meanwhile, Asia Pacific is expected to register the fastest market growth during the forecast period.
Rapid urbanization, changing dietary habits, growing healthcare investments, improving hospital infrastructure, and increasing awareness regarding kidney health are driving demand for advanced urological treatments across China, India, Japan, and Southeast Asia.
The expanding availability of minimally invasive surgical procedures further supports strong regional market growth.
Competitive Landscape
The global ureteral stents market remains moderately consolidated, with leading manufacturers investing heavily in product innovation, strategic collaborations, acquisitions, and global expansion.
Major companies operating in the market include Boston Scientific Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Americas, Coloplast Corporation, Merit Medical Systems, Inc., and Becton, Dickinson, and Company.
These organizations continue focusing on the development of advanced biomaterials, antimicrobial coatings, biodegradable stents, patient-centric designs, and minimally invasive delivery systems to strengthen their competitive positions.
Recent Industry Developments
The ureteral stents industry has witnessed several noteworthy product innovations.
In May 2022, the Relief™ Ureteral Stent, developed by Dr. Lee Ponsky in collaboration with Dean Secrest at University Hospitals Cleveland, received FDA 510(k) clearance. The device was designed to improve urinary drainage for patients suffering from kidney stones and other obstructive urological conditions.
In April 2022, Boston Scientific Corporation received a Bronze Edison Award for its Tria™ Ureteral Stent, featuring proprietary surface technology engineered to reduce calcium and magnesium salt deposition, thereby minimizing encrustation and improving long-term stent performance.
Future Outlook
The outlook for the global ureteral stents market remains highly favorable as healthcare systems increasingly adopt minimally invasive urological procedures and advanced urinary drainage technologies.
Growing prevalence of kidney stones, urinary tract infections, ureteral strictures, and age-related urological disorders will continue driving long-term demand.
Ongoing innovations in biodegradable materials, antimicrobial coatings, drug-eluting technologies, and patient-friendly stent designs are expected to improve treatment outcomes while reducing complications associated with long-term stenting.
Combined with expanding healthcare infrastructure, rising awareness of early diagnosis, and continued technological advancement, these factors are expected to support sustained growth of the global ureteral stents market through 2031.
Buy Full Report Now: https://www.transparencymarketresearch.com/checkout.php?rep_id=25988<ype=S
→Explore Latest Research Reports by Transparency Market Research:
Pulmonary Drug Delivery Devices Market
Proliferative Diabetic Retinopathy Market
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Media Contact:Â
Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY – 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website:Â https://www.transparencymarketresearch.com
Sales Inquiries:Â sales@transparencymarketresearch.com
Media Inquiries:Â media@transparencymarketresearch.com
Leave a Reply